Donald Trump’s 200% tariffs on pharma: Why India’s generic medicines could still remain competitive
Trump said generic drug imports would remain exempt from tariffs for the next two years. Beginning in August 2028, they would attract a 100% tariff. (AP photo) In a blow to India’s pharmaceutical industry, the Donald Trump administration has announced up to 200% tariffs on generic drugs that will be applicable in the coming years.US…